Family Management Cut By $1.71 Million Its Cisco Sys (CSCO) Stake; Rigel Pharmaceuticals, Inc. (RIGL) Covered By 4 Bulls

October 13, 2017 - By test

Family Management Corp decreased Cisco Sys Inc (CSCO) stake by 27.37% reported in 2017Q2 SEC filing. Family Management Corp sold 55,162 shares as Cisco Sys Inc (CSCO)’s stock declined 7.50%. The Family Management Corp holds 146,394 shares with $4.58 million value, down from 201,556 last quarter. Cisco Sys Inc now has $165.74B valuation. The stock increased 0.63% or $0.21 during the last trading session, reaching $33.47. About 13.45 million shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 13.20% since October 13, 2016 and is uptrending. It has underperformed by 3.50% the S&P500.

Among 4 analysts covering Rigel Pharmaceuticals (NASDAQ:RIGL), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Rigel Pharmaceuticals had 11 analyst reports since August 8, 2015 according to SRatingsIntel. BMO Capital Markets maintained the stock with “Outperform” rating in Wednesday, August 31 report. The firm has “Buy” rating by Jefferies given on Monday, September 4. Zacks upgraded Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) rating on Saturday, August 8. Zacks has “Hold” rating and $3.25 target. Piper Jaffray maintained it with “Overweight” rating and $11 target in Tuesday, August 30 report. The company was maintained on Monday, October 2 by BMO Capital Markets. The firm earned “Buy” rating on Wednesday, June 7 by BMO Capital Markets. The stock of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has “Buy” rating given on Monday, May 16 by Jefferies. The firm has “Buy” rating given on Wednesday, July 13 by H.C. Wainwright. The rating was maintained by BMO Capital Markets on Monday, June 19 with “Buy”. Piper Jaffray initiated the shares of RIGL in report on Monday, June 13 with “Overweight” rating. See Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) latest ratings:

02/10/2017 Broker: BMO Capital Markets Rating: Buy New Target: $5.0 Maintain
04/09/2017 Broker: Jefferies Rating: Buy New Target: $5.0 Maintain
19/06/2017 Broker: BMO Capital Markets Rating: Buy New Target: $5.0000 Maintain
07/06/2017 Broker: BMO Capital Markets Rating: Buy New Target: $4.0000 Maintain

Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The company has market cap of $535.11 million. The Firm is engaged in the discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases. It currently has negative earnings. The Company’s pioneering research focuses on signaling pathways that are critical to disease mechanisms.

The stock decreased 1.82% or $0.07 during the last trading session, reaching $3.77. About 3.87M shares traded or 69.00% up from the average. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has risen 4.56% since October 13, 2016 and is uptrending. It has underperformed by 12.14% the S&P500.

Investors sentiment increased to 1.59 in 2017 Q2. Its up 0.37, from 1.22 in 2017Q1. It increased, as 4 investors sold Rigel Pharmaceuticals, Inc. shares while 28 reduced holdings. 16 funds opened positions while 35 raised stakes. 105.05 million shares or 0.54% more from 104.49 million shares in 2017Q1 were reported. State Board Of Administration Of Florida Retirement Systems has invested 0% of its portfolio in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Connor Clark And Lunn Mgmt Limited owns 127,923 shares. Dafna Cap Mngmt Ltd Co invested in 443,478 shares or 0.86% of the stock. D E Shaw And Company has 1.36M shares for 0.01% of their portfolio. New York-based Millennium Management Ltd Liability Co has invested 0.02% in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Illinois-based Gru One Trading Lp has invested 0% in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Moreover, Rhenman Prtn Asset has 0.54% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) for 1.38 million shares. Morgan Stanley reported 206,560 shares or 0% of all its holdings. Hudson Bay Mgmt Limited Partnership has 0.05% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) for 1.00M shares. Oppenheimer Inc has invested 0.01% of its portfolio in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Jpmorgan Chase & owns 1.46M shares. Fmr Ltd Co reported 18.36 million shares. Nea Management Limited Liability Company holds 0.32% or 3.24M shares in its portfolio. Moreover, Credit Suisse Ag has 0% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Moreover, Axa has 0% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL).

Among 37 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 23 have Buy rating, 0 Sell and 14 Hold. Therefore 62% are positive. Cisco Systems Inc. had 113 analyst reports since August 4, 2015 according to SRatingsIntel. On Thursday, August 18 the stock rating was maintained by Wunderlich with “Hold”. The rating was maintained by Credit Suisse on Wednesday, June 21 with “Buy”. The firm has “Buy” rating by Wells Fargo given on Friday, July 21. Oppenheimer maintained it with “Buy” rating and $3600 target in Wednesday, June 28 report. The rating was initiated by Drexel Hamilton on Friday, October 9 with “Buy”. The company was maintained on Wednesday, August 2 by Jefferies. The rating was maintained by Drexel Hamilton with “Buy” on Tuesday, August 15. The firm has “Buy” rating given on Wednesday, June 21 by Oppenheimer. The firm earned “Underperform” rating on Thursday, August 18 by Credit Suisse. The firm has “Buy” rating given on Thursday, August 17 by Robert W. Baird.

Investors sentiment increased to 1.18 in 2017 Q2. Its up 0.14, from 1.04 in 2017Q1. It is positive, as 90 investors sold CSCO shares while 594 reduced holdings. 111 funds opened positions while 694 raised stakes. 3.60 billion shares or 0.67% less from 3.62 billion shares in 2017Q1 were reported. Principal Inc accumulated 12.94 million shares. Tci Wealth Advsrs holds 0.24% or 14,760 shares. Brighton Jones Limited Company invested in 45,259 shares or 0.2% of the stock. Pinnacle Lc stated it has 0% in Cisco Systems, Inc. (NASDAQ:CSCO). Quantum Cap Mgmt reported 40,664 shares or 0.31% of all its holdings. Palladium Prtn Ltd Limited Liability Company reported 1.08% in Cisco Systems, Inc. (NASDAQ:CSCO). Park Circle Co reported 20,000 shares. Minnesota-based Thrivent For Lutherans has invested 0.93% in Cisco Systems, Inc. (NASDAQ:CSCO). Moreover, Woodmont Investment Counsel Limited Liability Corporation has 0.44% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 50,372 shares. Country Trust Bancshares reported 1.23 million shares. Partners Limited Oh Adv invested in 22,282 shares. Amp Cap owns 0.49% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 2.65M shares. Natl Pension Service stated it has 3.80M shares. Stewart West Indies Trading holds 4.98% or 1.82M shares in its portfolio. Ajo Limited Partnership, a Pennsylvania-based fund reported 228,837 shares.

Family Management Corp increased Amgen Inc (NASDAQ:AMGN) stake by 23,775 shares to 25,775 valued at $4.44M in 2017Q2. It also upped Pepsico Inc (NYSE:PEP) stake by 14,133 shares and now owns 31,970 shares. Facebook Inc (NASDAQ:FB) was raised too.

Analysts await Cisco Systems, Inc. (NASDAQ:CSCO) to report earnings on November, 15. They expect $0.55 earnings per share, 0.00% or $0.00 from last year’s $0.55 per share. CSCO’s profit will be $2.72 billion for 15.21 P/E if the $0.55 EPS becomes a reality. After $0.55 actual earnings per share reported by Cisco Systems, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since May 24, 2017, it had 0 insider buys, and 3 sales for $12.50 million activity. Jacoby Rebecca had sold 92,840 shares worth $2.94 million. $9.31M worth of Cisco Systems, Inc. (NASDAQ:CSCO) was sold by CHAMBERS JOHN T on Wednesday, May 24. 7,802 shares valued at $244,125 were sold by Walker Karen on Sunday, June 11.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com